| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214992 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 9 Pages |
Abstract
This multicenter observational study suggests a potential benefit of adding rituximab to radiation therapy for stage I-II FL. The results of the currently ongoing randomized studies are required to confirm these results. The study underlines the importance of molecular disease monitoring also for patient with limited-stage disease.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Marco MD, Andrea Riccardo MD, Riccardo MD, Anna MD, Michele MD, Daniele MD, Roberto MSc, Paola MD, Massimo MD, Paolo MD, Guido MD, Guido MD, Attilio MD, Marco MD, PhD, Umberto MD, Corrado MD, PhD, Liliana MD,